Tango Therapeutics, Inc. (TNGX): Price and Financial Metrics

Tango Therapeutics, Inc. (TNGX): $6.09

0.16 (+2.70%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add TNGX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#276 of 308

in industry

TNGX Price/Volume Stats

Current price $6.09 52-week high $12.02
Prev. close $5.93 52-week low $1.03
Day low $5.83 Volume 1,407,100
Day high $6.40 Avg. volume 1,748,166
50-day MA $3.54 Dividend yield N/A
200-day MA $3.44 Market Cap 660.12M

TNGX Stock Price Chart Interactive Chart >


Tango Therapeutics, Inc. (TNGX) Company Bio


Tango Therapeutics, Inc., a biotechnology company, discovers and develops medicines for the treatment of cancer. Its lead program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor that treats cancers with BRCA1 mutations. Tango Therapeutics, Inc. has strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.


TNGX Latest News Stream


Event/Time News Detail
Loading, please wait...

TNGX Latest Social Stream


Loading social stream, please wait...

View Full TNGX Social Stream

TNGX Price Returns

1-mo 29.85%
3-mo 375.78%
6-mo 119.06%
1-year -39.22%
3-year 35.03%
5-year N/A
YTD 97.09%
2024 -68.79%
2023 36.55%
2022 -33.73%
2021 -4.37%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!